Inactive Instrument

Company Pherecydes Pharma

Equities

35L

FR0011651694

Business Summary

Pherecydes Pharma is specialized in the research and development of anti-infective therapies based on bacteriophages. Phagotherapy is an innovative approach to treat bacterial infections, including antibiotic-resistant infections, using phages, natural predators of bacteria that have no effect on eukaryotic cells, including human cells.

Number of employees: 29

Company contact information

Pherecydes Pharma SA

22 boulevard Benoni Goullin

44200, Nantes

+33 1 48 40 65 35

http://pherecydes-pharma.com
address Pherecydes Pharma(35L)

Sector

This company's sector is not yet available
  1. Stock Market
  2. Equities
  3. 35L Stock
  4. Company Pherecydes Pharma